Investigation in Progress — No Complaint Filed Yet
BG&G is actively investigating potential securities fraud claims against ICU Medical, Inc.. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ICU Medical, Inc. (“ICU Medical” or “the Company”) (NASDAQ: ICUI). Investors who purchased ICU Medical securities are encouraged to obtain additional information and assist the investigation.
The investigation concerns whether ICU Medical has violated federal securities laws.
Investigation Details
On April 22, 2025, ICU Medical received a warning letter from the Food and Drug Administration (“FDA”). According to the FDA, the Company “made multiple changes to the Medfusion Model 4000 Syringe Infusion Pump and CADD Solis VIP Ambulatory Infusion Pump that could significantly affect the safety or effectiveness of these devices.” The FDA states that the Company’s pumps were “adulterated” and “misbranded,” with modifications that “can significantly impact the functionality of the device with respect to the infusion pumps delivery profile, alarm functionality, etc., and affect the device’s risk profile.” Following this news, ICU Medical stock dropped.
What’s Next?
If you are aware of any facts relating to this investigation or purchased ICU Medical securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660
ICUI — Stock Performance
About Bronstein, Gewirtz & Grossman, LLC
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”